Trials / Terminated
TerminatedNCT01058850
Phase I Rindopepimut After Conventional Radiation in Children w/ Diffuse Intrinsic Pontine Gliomas
A Phase I Study of Rindopepimut After Conventional Radiation in Children With Diffuse Intrinsic Pontine Gliomas
- Status
- Terminated
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 3 (actual)
- Sponsor
- Paul Graham Fisher · Academic / Other
- Sex
- All
- Age
- 3 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a research study of patients with diffuse intrinsic pontine gliomas. We hope to learn about the safety and efficacy of treating pediatric diffuse intrinsic pontine glioma patients with the EGFRvIII peptide vaccine after conventional radiation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Rindopepimut | 250 or 500 mcg; intradermal injection |
Timeline
- Start date
- 2011-06-01
- Primary completion
- 2013-09-01
- Completion
- 2013-09-01
- First posted
- 2010-01-29
- Last updated
- 2021-09-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01058850. Inclusion in this directory is not an endorsement.